Monthly Archives: June 2022

More bad news for patients with Alzheimer’s disease.

        Btobioinnovation.com  Author: Jean-Claude Muller, 穆卓Executive Editor at BtoBioInnovation  jcm9144@gmail.com       SPECIAL REPORT #22.10     More bad news for patients with Alzheimer’s disease.     On June 16, Roche reported that crenezumab, a beta amyloid monoclonal antibody, failed in the closely watched Phase II API-ADAD trial. Roche stated that only […]

read more